Galanin pathogenic mutations in temporal lobe epilepsy

Human Molecular Genetics

Volumn 24, Issue 11, 2014, Pages 3082-3091

  Guipponi, Michel ^a   Chentouf, Amina ^b   Webling, Kristin E B ^c   Freimann, Krista ^c,d   Crespel, Arielle ^e   Nobile, Carlo ^f   Lemke, Johannes R ^g,h   Hansen, Jörg ⁱ   Dorn, Thomas ⁱ   Lesca, Gaetan ^j,k,l   Ryvlin, Philippe ^l,m,n   Hirsch, Edouard ^o   Rudolf, Gabrielle ^o   Rosenberg, Dominique Sarah ^p   Weber, Yvonne ^q   Becker, Felicitas ^q   Helbig, Ingo ^r,s   Muhle, Hiltrud ^r   Salzmann, Annick ^a   Chaouch, Malika ^t   Oubaiche, Mohand Laid ^b   Ziglio, Serena ^u   Gehrig, Corinne ^a   Santoni, Federico ^a   Pizzato, Massimo ^u   Langel, Ülo ^c   Antonarakis, Stylianos E ^a,v   more..

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b CHU Oran   (Algeria)

^c STOCKHOLM UNIVERSITY   (Sweden)

^d UNIVERSITY OF TARTU   (Estonia)

^e MONTPELLIER UNIVERSITY HOSPITAL   (France)

^f CNR   (Italy)

^g UNIVERSITY OF BERN   (Switzerland)

^h UNIVERSITY OF LEIPZIG   (Germany)

ⁱ SWISS EPILEPSY CENTER   (Switzerland)

^j HOSPICES CIVILS DE LYON   (France)

^k UNIVERSITÉ LYON 1   (France)

^l LYON NEUROSCIENCE RESEARCH CENTER   (France)

^m LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

ⁿ HCL   (France)

^o UNIVERSITÉ DE STRASBOURG   (France)

^p UNIVERSITÉ CLERMONT AUVERGNE   (France)

^q UNIVERSITY OF TÜBINGEN   (Germany)

^r UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^s CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^t Benaknoun University Hospital   (Algeria)

^u UNIVERSITY OF TRENTO   (Italy)

^v Institute of Genetics and Genomics in Geneva (iGE3)   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; GALANIN; GALANIN RECEPTOR 1; GAL PROTEIN, HUMAN; PROTEIN BINDING;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; EXOME; EXON; FRAMESHIFT MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENETIC VARIABILITY; HIPPOCAMPUS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MONOZYGOTIC TWINS; MUTATIONAL ANALYSIS; NONSENSE MUTATION; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION; TEMPORAL LOBE EPILEPSY; ANIMAL; CHO CELL LINE; CRICETULUS; DNA MUTATIONAL ANALYSIS; GENETIC ASSOCIATION STUDY; GENETICS; HAMSTER; NUCLEOTIDE SEQUENCE; PEDIGREE; TWINS;

ANIMALIA;

ADULT; ANIMALS; BASE SEQUENCE; CHO CELLS; CRICETINAE; CRICETULUS; DNA MUTATIONAL ANALYSIS; EPILEPSY, TEMPORAL LOBE; GALANIN; GENETIC ASSOCIATION STUDIES; HUMANS; MUTATION, MISSENSE; PEDIGREE; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 84930688916     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv060     Document Type: Article

References (34)

1. Manford, M., Hart, Y.M., Sander, J.W. and Shorvon, S.D. (1992) National General Practice Study of Epilepsy (NGPSE): partial seizure patterns in a general population. Neurology, 42, 1911-1917.
2. Berkovic, S.F., McIntosh, A., Howell, R.A., Mitchell, A., Sheffield, L.J. and Hopper, J.L. (1996) Familial temporal lobe epilepsy:a common disorder identified in twins. Ann. Neurol., 40, 227-235.
3. Vadlamudi, L., Scheffer, I.E. and Berkovic, S.F. (2003) Genetics of temporal lobe epilepsy. J. Neurol. Neurosurg. Psychiatry, 74, 1359-1361.
4. Schulte, U., Thumfart, J.O., Klocker, N., Sailer, C.A., Bildl, W., Biniossek, M., Dehn, D., Deller, T., Eble, S., Abbass, K. et al. (2006) The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvbeta1. Neuron, 49, 697-706.
5. Dibbens, L.M., de Vries, B., Donatello, S., Heron, S.E., Hodgson, B.L., Chintawar, S., Crompton, D.E., Hughes, J.N., Bellows, S.T., Klein, K.M. et al. (2013) Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat. Genet., 45, 546-551.
6. Bar-Peled, L., Chantranupong, L., Cherniack, A.D., Chen, W. W., Ottina, K.A., Grabiner, B.C., Spear, E.D., Carter, S.L., Meyerson, M. and Sabatini, D.M. (2013) A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science, 340, 1100-1106.
7. Tatemoto, K., Rokaeus, A., Jornvall, H., McDonald, T.J. and Mutt, V. (1983) Galanin-a novel biologically active peptide from porcine intestine. FEBS Lett., 164, 124-128.
8. Mechenthaler, I. (2008) Galanin and the neuroendocrine axes. Cell. Mol. Life Sci., 65, 1826-1835.
9. Mazarati, A.M., Halaszi, E. and Telegdy, G. (1992) Anticonvulsive effects of galanin administered into the central nervous system upon the picrotoxin-kindled seizure syndrome in rats. Brain Res., 589, 164-166.
10. Lerner, J.T., Sankar, R. and Mazarati, A.M. (2008) Galanin and epilepsy. Cell Mol. Life Sci., 65, 1864-1871.
11. Lu, X., Roberts, E., Xia, F., Sanchez-Alavez, M., Liu, T., Baldwin, R., Wu, S., Chang, J., Wasterlain, C.G. and Bartfai, T. (2010) GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models. Proc. Natl. Acad. Sci U S A, 107, 15229-15234.
12. Nikitidou, L., Torp, M., Fjord-Larsen, L., Kusk, P.,Wahlberg, L. U. and Kokaia, M. (2014) Encapsulated galanin-producing cells attenuate focal epileptic seizures in the hippocampus. Epilepsia, 55, 167-174.
13. Chiquet, B.T., Lidral, A.C., Stal, S., Mulliken, J.B., Moreno, L.M., Arcos-Burgos, M., Valencia-Ramirez, C., Blanton, S.H. and Hecht, J.T. (2007) CRISPLD2: a novel NSCLP candidate gene. Hum. Mol. Genet., 16, 2241-2248.
14. Shi, J., Jiao, X., Song, T., Zhang, B., Qin, C. and Cao, F. (2010) CRISPLD2 polymorphisms are associated with non-syndromic cleft lip with or without cleft palate in a northern Chinese population. Eur. J. Oral Sci., 118, 430-433.
15. Letra, A., Menezes, R., Cooper, M.E., Fonseca, R.F., Tropp, S., Govil, M., Granjeiro, J.M., Imoehl, S.R., Mansilla, M.A., Murray, J.C. et al. (2011) CRISPLD2 variants including a C471 T silent mutation may contribute to nonsyndromic cleft lip with or without cleft palate. Cleft. Palate Craniofac. J., 48, 363-370.
16. Girardi, A., Martinelli, M., Carinci, F., Morselli, P.G., Caramelli, E. and Scapoli, L. (2011) No evidence for a role of CRISPLD2 in non-syndromic cleft lip with or without cleft palate in an Italian population. Eur. J. Oral. Sci., 119, 102-105.
17. Webling, K.E., Runesson, J., Bartfai, T. and Langel, U. (2012) Galanin receptors and ligands. Front. Endocrinol. (Lausanne), 3, 146.
18. Evans, H., Baumgartner, M., Shine, J. and Herzog, H. (1993) Genomic organization and localization of the gene encoding human preprogalanin. Genomics, 18, 473-477.
19. Land, T., Langel, U. and Bartfai, T. (1991) Hypothalamic degradation of galanin(1-29) and galanin(1-16): identification and characterization of the peptidolytic products. Brain Res., 558, 245-250.
20. Land, T., Langel, U., Low, M., Berthold, M., Unden, A. and Bartfai, T. (1991) Linear and cyclic N-terminal galanin fragments and analogs as ligands at the hypothalamic galanin receptor. Int. J. Pept. Protein Res., 38, 267-272.
21. Bedecs, K., Langel, U. and Bartfai, T. (1995) Metabolism of galanin and galanin (1-16) in isolated cerebrospinal fluid and spinal cord membranes from rat. Neuropeptides, 29, 137-143.
22. Mazarati, A.M., Liu, H., Soomets, U., Sankar, R., Shin, D., Katsumori, H., Langel, U. and Wasterlain, C.G. (1998) Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus. J. Neurosci., 18, 10070-10077.
23. Mazarati, A.M., Hohmann, J.G., Bacon, A., Liu, H., Sankar, R., Steiner, R.A., Wynick, D. andWasterlain, C.G. (2000) Modulation of hippocampal excitability and seizures by galanin. J. Neurosci., 20, 6276-6281.
24. Lang, R., Gundlach, A.L. and Kofler, B. (2007) The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol. Ther., 115, 177-207.
25. Mennicken, F., Hoffert, C., Pelletier, M., Ahmad, S. and O'Donnell, D. (2002) Restricted distribution of galanin receptor 3 (GalR3) mRNA in the adult rat central nervous system. J. Chem. Neuroanat., 24, 257-268.
26. Zini, S., Roisin, M.P., Langel, U., Bartfai, T. and Ben-Ari, Y. (1993) Galanin reduces release of endogenous excitatory amino acids in the rat hippocampus. Eur. J. Pharmacol., 245, 1-7.
27. Schauwecker, P.E. (2010) Galanin receptor 1 deletion exacerbates hippocampal neuronal loss after systemic kainate administration in mice. PLoS One, 5, e15657.
28. Tellez-Zenteno, J.F. and Hernandez-Ronquillo, L. (2012) A review of the epidemiology of temporal lobe epilepsy. Epilepsy Res. Treat, 2012, 630853.
29. Proposal for revised classification of epilepsies and epileptic syndromes. (1989) Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia, 30, 389-399.
30. Santoni, F.A., Makrythanasis, P., Nikolaev, S., Guipponi, M., Robyr, D., Bottani, A. and Antonarakis, S.E. (2014) Simultaneous identification and prioritization of variants in familial, de novo, and somatic genetic disorders with VariantMaster. Genome Res., 24, 349-355.
31. Cheng, Y. and Prusoff, W.H. (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol., 22, 3099-3108.
32. Solly, K., Wang, X., Xu, X., Strulovici, B. and Zheng, W. (2004) Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays. Assay Drug Dev. Technol., 2, 363-372.
33. Scott, C.W. and Peters, M.F. (2010) Label-free whole-cell assays:expanding the scope of GPCR screening. Drug Discov. Today, 15, 704-716.
34. Stallaert,W., Dorn, J.F., van derWesthuizen, E., Audet, M. and Bouvier, M. (2012) Impedance responses reveal beta(2)-adrenergic receptor signaling pluridimensionality and allowclassification of ligands with distinct signaling profiles. PLoS One, 7, e29420.